The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.
| Non-serious case reports | ||
| Drug name(s) | Adverse event(s) | No. of cases |
| Abiraterone acetate, Carboplatin, Docetaxel, Leuprorelin, Prednisone, Yttrium 90 | Fatigue, Nausea, Vomiting | 1 |
| Adalimumab | Vitiligo | 1 |
| Aluminium, DTaP poliovirus vaccine | Exanthema, Injection site reactions, Pruritus | 1 |
| Ampicillin, Sulbactam | Eczema, Hypersensitivity | 1 |
| Articaine/epinephrine | Diplopia | 1 |
| AZD 1222 | Skin eruptions | 5 |
| Bendamustine, Rituximab | Sinus histiocytosis | 1 |
| Bicalutamide | Gynaecomastia | 1 |
| Bictegravir/emtricitabine/tenofovir alafenamide | Pruritus | 1 |
| BNT 162b1 | Chills, Fatigue, Headache, Hypersensitivity, Muscle pain | 3 |
| Botulinum Toxin A | Dysphonia, Gastrointestinal disorders, Mouth disorders | 3 |
| Bupivacaine, Fentanyl, Lidocaine, Midazolam | Paraesthesia, Tinnitus | 1 |
| Cisplatin, Fluorouracil | Diarrhoea, Nausea, Vomiting | 1 |
| Clarithromycin, Ethambutol, Rifampicin | Diarrhoea | 1 |
| Cotrimoxazole | Abnormal laboratory parameters | 1 |
| COVID 19 Vaccine Pfizer BioNTech | Lichen planus | 1 |
| Cytarabine/daunorubicin | Hyperpigmentation | 1 |
| Diltiazem, Leflunomide, Quetiapine | Oral ulcer | 1 |
| Doxycycline, Rifampicin | Abnormal laboratory parameters, Elevated aminotransferase levels | 1 |
| Erlotinib | Exanthema | 1 |
| Gimeracil/oteracil/tegafur, Temozolomide | Gastrointestinal disorders | 1 |
| Hydroxocobalamin | Injection site pain | 3 |
| Ibrutinib | Hypersensitivity | 1 |
| Infliximab | Abnormal laboratory parameters, False test results | 1 |
| Infliximab, Tozinameran | Herpes zoster | 1 |
| Ipratropium bromide | Anisocoria, Mydriasis | 1 |
| Lansoprazole, Nitisinone, Omeprazole | Vitiligo | 4 |
| Letrozole, Pyrotinib | Abnormal laboratory parameters, Diarrhoea | 1 |
| Methylphenidate | Gynaecomastia | 1 |
| Methylthioninium chloride | Abnormal laboratory parameters | 1 |
| Metoprolol | Sinus bradycardia | 1 |
| Metronidazole | Hairy tongue | 1 |
| mRNA 1273 | Delayed hypersensitivity | 3 |
| Pemigatinib | Nail disorders | 1 |
| Pertuzumab, Trastuzumab | Lichenoid eruptions | 1 |
| Polymixin B/bacitracin | Allergic contact dermatitis | 1 |
| Posaconazole | Elevated aminotransferase levels | 1 |
| Prochlorperazine | Hypersensitivity, Photosensitivity | 1 |
| Tozinameran | Asthenia, Headache, Injection site pain, Skin disorders | 1 |
| Tozinameran | Blood coagulation disorders, Exanthema, Injection site pain | 1 |
| Vonoprazan | Gastrointestinal disorders | 4 |
| Voriconazole | Fatigue, Flu like symptoms, Muscle pain, Muscular disorders, Photophobia | 6 |
| Voriconazole | Photosensitivity | 1 |
Reference
- Non-serious case reports. Reactions Weekly 10 Nov 2021